Steward Partners Investment Advisory’s Oramed Pharmaceuticals ORMP Stock Holding History

Steward Partners Investment Advisory’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30K	Sell	8,826 -440	-5%	-$1.49K	﹤0.01%	3044
2025 Q4	$26.4K	Buy	9,266 +440	+5%	+$1.14K	﹤0.01%	3017
2025 Q3	$23.3K	Hold	8,826	–	–	﹤0.01%	3021
2025 Q2	$19.9K	Hold	8,826	–	–	﹤0.01%	2927
2025 Q1	$18.9K	Hold	8,826	–	–	﹤0.01%	2831
2024 Q4	$21.4K	Hold	8,826	–	–	﹤0.01%	2757
2024 Q3	$21.5K	Hold	8,826	–	–	﹤0.01%	2635
2024 Q2	$22.7K	Hold	8,826	–	–	﹤0.01%	2469
2024 Q1	$25.8K	Buy	+8,826	New	+$24.7K	﹤0.01%	2412
2023 Q2	–	Sell	-1,000	Closed	-$2.18K	–	3368
2023 Q1	$2.18K	Hold	1,000	–	–	﹤0.01%	3003
2022 Q4	$12K	Hold	1,000	–	–	﹤0.01%	2470
2022 Q3	$6K	Sell	1,000 -1,000	-50%	-$8.09K	﹤0.01%	2711
2022 Q2	$9K	Hold	2,000	–	–	﹤0.01%	2563
2022 Q1	$17K	Hold	2,000	–	–	﹤0.01%	2449
2021 Q4	$29K	Sell	2,000 -500	-20%	-$10.5K	﹤0.01%	2164
2021 Q3	$55K	Buy	2,500 +1,000	+67%	+$17K	﹤0.01%	1840
2021 Q2	$20K	Sell	1,500 -60,000	-98%	-$686K	﹤0.01%	5106
2021 Q1	$625K	Buy	61,500 +60,000	+4,000%	+$492K	0.01%	803
2020 Q4	$6K	Buy	+1,500	New	+$4.88K	﹤0.01%	2471
2020 Q3	–	Sell	-1,000	Closed	-$4K	–	2816
2020 Q2	$4K	Hold	1,000	–	–	﹤0.01%	2334
2020 Q1	$3K	Hold	1,000	–	–	﹤0.01%	2227
2019 Q4	$5K	Hold	1,000	–	–	﹤0.01%	2244
2019 Q3	$3K	Hold	1,000	–	–	﹤0.01%	2367
2019 Q2	$3K	Buy	+1,000	New	+$3.53K	﹤0.01%	2363
2018 Q4	–	Sell	-300	Closed	-$1K	–	1712
2018 Q3	$1K	Hold	300	–	–	﹤0.01%	2510
2018 Q2	$2K	Hold	300	–	–	﹤0.01%	2238
2018 Q1	$1K	Hold	300	–	–	﹤0.01%	2151
2017 Q4	$2K	Buy	+300	New	+$2.87K	﹤0.01%	1710

Other funds holding ORMP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Steward Partners Investment Advisory's ORMP Position: Q1 2026 in Review

Steward Partners Investment Advisory reduced its Oramed Pharmaceuticals (ORMP) stake by 4.7% in Q1 2026, selling an estimated $1.49K and leaving 8,826 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

Steward Partners Investment Advisory first reported a position in ORMP in Q4 2017 and has held it in 28 quarters since. The position peaked at $625K in Q1 2021. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

Steward Partners Investment Advisory held 8,826 shares of Oramed Pharmaceuticals worth $30K as of Q1 2026.
Steward Partners Investment Advisory sold 440 Oramed Pharmaceuticals shares in Q1 2026, an estimated $1.49K.
Oramed Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3044 holding.
Steward Partners Investment Advisory first reported a position in Oramed Pharmaceuticals in Q4 2017 and has held it in 28 quarters since.
Steward Partners Investment Advisory's Oramed Pharmaceuticals position peaked at $625K in Q1 2021.
64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.